Does RAMIPRIL Cause Neoplasm malignant? 18 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Neoplasm malignant have been filed in association with RAMIPRIL (Ramipril). This represents 0.1% of all adverse event reports for RAMIPRIL.
18
Reports of Neoplasm malignant with RAMIPRIL
0.1%
of all RAMIPRIL reports
7
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm malignant From RAMIPRIL?
Of the 18 reports, 7 (38.9%) resulted in death, 4 (22.2%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which RAMIPRIL Alternatives Have Lower Neoplasm malignant Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE